数据链接：
官方服务：
资源简介：
Phase 4 participant demographics by site.
应用场景：
创建时间：
2021-10-20
相关数据集
Required Clinical Trial After Approval Database
This dataset is the main file to construct the FDA (U.S. Food and Drug Administration) Postmarketing Requirements and Commitments searchable database. Postmarketing requirements refers to studies requ
www.johnsnowlabs.com160
Effectiveness outcome after the final injection.
This study aimed to assess the safety and effectiveness of the highly cross-linked hyaluronic acid—LBSA0103—in patients with knee osteoarthritis (OA) as per the prescribing information (PI) in South K
Figshare2023-06-22 更新110
Demographic details of participants according to whether they attended or did not attend all treatment visits.
Demographic details of participants according to whether they attended or did not attend all treatment visits.
NIAID Data Ecosystem90
Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance
We investigated the long-term safety and effectiveness of linagliptin in Japanese type 2 diabetes (T2D) patients starting linagliptin add-on therapy in routine clinical practice. This 3-year prospecti
Figshare2021-01-07 更新120
Demographic Characteristics of VOICE-C Ancillary Study Participants.
*Other ethnic groups: Kalanga = 1, Khalanga = 1, Nyanja = 1, Shona = 2, Swati = 1, Swazi = 1, Tsonga = 3, Tswana = 4, Venda = 3. **The procedural changes resulting from VOICE Data Safety and Monitorin
NIAID Data Ecosystem90
